|
Zbtb family members in lymphocyte differentiation and function
|
ZIA BC 011429
|
$341,950
|
$341,950
|
Kovalovsky, Damian
|
CCR (NCI)
|
|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific
|
1R13AT009161-01
|
$5,000
|
$5,000
|
Price, Theodore
|
AMERICAN PAIN SOCIETY
|
|
Yale Cancer Biology Training Grant
|
1T32CA193200-01A1
|
$231,708
|
$231,708
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
Workshop on Techniques in Modeling Human Cancer in Mice
|
5R25CA172010-03
|
$70,396
|
$70,396
|
MILLS, KEVIN
|
JACKSON LABORATORY
|
|
Women's Interagency HIV Study (WIHS-V)
|
5U01AI035004-24
|
$144,370
|
$144,370
|
ANASTOS, KATHRYN
|
"ALBERT EINSTEIN COLLEGE OF MEDICINE, IN
|
|
Wisconsin NCI Community Oncology Research Program (WiNCORP)
|
5UG1CA189956-03
|
$1,478,551
|
$1,478,551
|
ONITILO, ADEDAYO
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
|
5UM1CA186716-03
|
$567,987
|
$567,987
|
KAUFMAN, HOWARD
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
WIHS Data Management and Analysis Center (WDMAC)
|
4U01AI042590-19
|
$95,311
|
$95,311
|
Gange, Stephen
|
JOHNS HOPKINS UNIVERSITY
|
|
Why red-haired individuals are so prone to developing melanoma
|
5R01CA196896-02
|
$374,464
|
$374,464
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
WEBSITE AND COMMUNICATION SERVICES FOR DCCPS. PERIOD OF PERFORMANCE 07/01/2016-06/30/2017.
|
261201200010I
|
$4,757,652
|
$4,757,652
|
UNKNOWN, UNKNOWN
|
ICF MACRO, INC.
|
|
WEB BASED EDUCATIONAL MODULE PROVIDING TRAINING ON THE 2017 SOLID TUMOR MULTIPLE PRIMARY AND HISTOLOGY CODING RULES
|
261201600780P
|
$22,030
|
$22,030
|
UNKNOWN, UNKNOWN
|
NATIONAL CANCER REGISTRAR'S ASSOCIATION
|
|
Washington Women's Interagency HIV/AIDS Study
|
4U01AI034994-23
|
$106,140
|
$106,140
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
WASHINGTON UNIVERSITY PAUL CALABRESI CAREER DEVELOPMENT AWARD FOR CLINICAL ONCOLO
|
4K12CA167540-05
|
$1,043,545
|
$1,043,545
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Washington University Cancer Genomics and Outcomes Research STRENGTH Program
|
5R25CA190190-02
|
$200,406
|
$200,406
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and HA Signaling in TNBC
|
5R01CA194500-02
|
$352,275
|
$352,275
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
|
5R01CA164225-05
|
$15,589
|
$15,589
|
WANG, LI
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-02
|
$912,000
|
$912,000
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors
|
5R01CA178932-03
|
$402,550
|
$402,550
|
O'SHEA, CLODAGH
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Viral oncoprotein targeted immune therapy for Merkel cell carcinoma
|
4R01CA176841-04
|
$637,515
|
$637,515
|
NGHIEM, PAUL
|
UNIVERSITY OF WASHINGTON
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-13
|
$399,000
|
$399,000
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
ViKTriY-PC Consortium Phase II Supplement
|
3UM1CA186689-03S1
|
$732,368
|
$732,368
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
ViKTriY Early Clinical Trials Consortium (ECTC)
|
5UM1CA186689-03
|
$1,362,459
|
$1,362,459
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis
|
5R01CA181648-03
|
$311,847
|
$311,847
|
LANG, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-03
|
$951,712
|
$951,712
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Leukocytes Influence the Tumor Microenvironment
|
4R01CA124515-11
|
$350,170
|
$350,170
|
CONEJO-GARCIA, JOSE
|
WISTAR INSTITUTE
|
|
Validation of the Fes Tyrosine Kinase as an Inhibitor Target in Multiple Myeloma
|
5R21CA185702-02
|
$200,970
|
$200,970
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Validation of EGFR Protein Complexes as Molecular Diagnostics
|
1UH2CA202970-01
|
$390,763
|
$390,763
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
|
2U01CA152662-06
|
$715,735
|
$715,735
|
MASSION, PIERRE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens
|
1R33CA204510-01
|
$365,264
|
$365,264
|
AKSAN, ALPTEKIN
|
UNIVERSITY OF MINNESOTA
|
|
Validation of a rapid point-of-care breath test for breast cancer
|
1R44CA203019-01A1
|
$1,071,867
|
$1,071,867
|
PHILLIPS, MICHAEL
|
MENSSANA RESEARCH, INC.
|
|
Validation of 4-miRNA signature for early lung cancer detection
|
1R21CA205414-01
|
$218,987
|
$218,987
|
CHEN, GUOAN
|
UNIVERSITY OF MICHIGAN
|
|
Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research
|
5R33CA191110-02
|
$240,355
|
$240,355
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Validation and Advanced Development of Duplex Sequencing
|
5R33CA181771-03
|
$377,887
|
$377,887
|
LOEB, LAWRENCE
|
UNIVERSITY OF WASHINGTON
|
|
Validating the protein binding domain of replication protein A as a cancer target
|
5R01CA174887-03
|
$325,775
|
$325,775
|
FESIK, STEPHEN
|
VANDERBILT UNIVERSITY
|
|
Validating the Patient-reported Experiences of Discrimination in Care Tool (PreDi
|
4R01CA169103-05
|
$644,476
|
$644,476
|
NUNEZ-SMITH, MARCELLA
|
YALE UNIVERSITY
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-02
|
$394,823
|
$394,823
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
Validating Low FDG Dose PET/CT compared to current Standard of Care Dose PET/CT
|
5R01CA195513-02
|
$352,275
|
$352,275
|
KNOPP, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Vaccination with the Tumor Self-Protein TP(D52) Elicits a Unique Subset of CD8+ T Cells
|
5R21CA191161-02
|
$166,388
|
$166,388
|
BRIGHT, ROBERT
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-02
|
$593,747
|
$593,747
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-02
|
$457,244
|
$457,244
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Using extracellular metabolites to understand and revert protumoral effects of Tumor-Associated Macrophages
|
5K99CA191021-02
|
$135,835
|
$135,835
|
CARMONA FONTAINE, CARLOS
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
1F30CA206424-01
|
$37,176
|
$37,176
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
|
ZIC SC 006537
|
$345,321
|
$345,321
|
Figg, William
|
CCR (NCI)
|
|
Using Adductomics to Characterize Exposures to Carcinogens
|
5R33CA191159-02
|
$379,613
|
$379,613
|
RAPPAPORT, STEPHEN
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-17
|
$275,994
|
$275,994
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unveiling the mechanism for Spartan-mediated DNA lesion bypass and the implications for breast cancer treatment
|
5F32CA192779-02
|
$58,002
|
$58,002
|
MOQUIN, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
|
5K08CA181475-04
|
$140,454
|
$140,454
|
VENNETI, SRIRAM
|
UNIVERSITY OF MICHIGAN
|
|
Unnatural Amino Acid Mutagenesis with Fluorescent Amino Acids
|
4F30CA174357-04
|
$48,576
|
$48,576
|
ANZALONE, ANDREW
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
University of Washington Center for Aids Research
|
4P30AI027757-29
|
$455,194
|
$455,194
|
Baeten, Jared
|
UNIVERSITY OF WASHINGTON
|
|
University of Rochester Center for AIDS Research
|
4P30AI078498-09
|
$197,997
|
$197,997
|
Dewhurst, Stephen
|
UNIVERSITY OF ROCHESTER
|
Total relevant funding to Cancer for this search: $1,791,076,187
|